AAAAAA

   
Results: 1-24 |
Results: 24
CLINICAL EFFECTS OF HUMAN MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA MIP-1-ALPHA (LD78) ADMINISTRATION TO HUMANS - A PHASE-I STUDY IN CANCER-PATIENTS AND NORMAL HEALTHY-VOLUNTEERS WITH THE GENETICALLY-ENGINEERED VARIANT, BB-10010
Authors: MARSHALL E HOWELL AH POWLES R HUNTER MG EDWARDS M WOOD LM CZAPLEWSKI L PUTTICK R WARRINGTON S BOYCE M TESTA N DEXTER TM LORD BI MILLAR A
Citation: E. Marshall et al., CLINICAL EFFECTS OF HUMAN MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA MIP-1-ALPHA (LD78) ADMINISTRATION TO HUMANS - A PHASE-I STUDY IN CANCER-PATIENTS AND NORMAL HEALTHY-VOLUNTEERS WITH THE GENETICALLY-ENGINEERED VARIANT, BB-10010, European journal of cancer, 34(7), 1998, pp. 1023-1029
INHIBITORS OF MATRIX METALLOPROTEINASES AS ANTIINFLAMMATORY AGENTS
Authors: WOOD LM
Citation: Lm. Wood, INHIBITORS OF MATRIX METALLOPROTEINASES AS ANTIINFLAMMATORY AGENTS, Journal of leukocyte biology, 1998, pp. 146-146
NO OUTSOURCING TREND
Authors: WOOD LM
Citation: Lm. Wood, NO OUTSOURCING TREND, Library journal, 123(9), 1998, pp. 8-8
RANDOMIZED PHASE-II STUDY OF BB-10010 (MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA) IN PATIENTS WITH ADVANCED BREAST-CANCER RECEIVING 5-FLUOROURACIL, ADRIAMYCIN, AND CYCLOPHOSPHAMIDE CHEMOTHERAPY
Authors: CLEMONS MJ MARSHALL E DURIG J WATANABE K HOWELL A MILES D EARL H KIERNAN J GRIFFITHS A TOWLSON K DETAKATS P TESTA NG DOUGAL M HUNTER MG WOOD LM CZAPLEWSKI LG MILLAR A DEXTER TM LORD BI
Citation: Mj. Clemons et al., RANDOMIZED PHASE-II STUDY OF BB-10010 (MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA) IN PATIENTS WITH ADVANCED BREAST-CANCER RECEIVING 5-FLUOROURACIL, ADRIAMYCIN, AND CYCLOPHOSPHAMIDE CHEMOTHERAPY, Blood, 92(5), 1998, pp. 1532-1540
MATRIX METALLOPROTEINASE EXPRESSION DURING EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS AND EFFECTS OF A COMBINED MATRIX METALLOPROTEINASE ANDTUMOR-NECROSIS-FACTOR-ALPHA INHIBITOR
Authors: CLEMENTS JM COSSINS JA WELLS GMA CORKILL DJ HELFRICH K WOOD LM PIGOTT R STABLER G WARD GA GEARING AJH MILLER KM
Citation: Jm. Clements et al., MATRIX METALLOPROTEINASE EXPRESSION DURING EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS AND EFFECTS OF A COMBINED MATRIX METALLOPROTEINASE ANDTUMOR-NECROSIS-FACTOR-ALPHA INHIBITOR, Journal of neuroimmunology, 74(1-2), 1997, pp. 85-94
EFFECTS OF THE PAF ANTAGONIST NUPAFANT HCL (BB-2113) ON ARRHYTHMIAS AND REPOLARIZATION DURING MYOCARDIAL-ISCHEMIA IN RAT HEARTS IN-VITRO
Authors: BAKER KE ROTHAUL AL WOOD LM WHITTAKER M CURTIS MJ
Citation: Ke. Baker et al., EFFECTS OF THE PAF ANTAGONIST NUPAFANT HCL (BB-2113) ON ARRHYTHMIAS AND REPOLARIZATION DURING MYOCARDIAL-ISCHEMIA IN RAT HEARTS IN-VITRO, British Journal of Pharmacology, 122, 1997, pp. 240-240
SITE OF ANTIARRHYTHMIC ACTION OF NUPAFANT HCL (BB-2113), ASSESSED BY SELECTIVE REGIONAL MYOCARDIAL PERFUSION IN THE RAT-HEART IN-VITRO
Authors: BAKER KE ROTHAUL AL WOOD LM WHITTAKER M CURTIS MJ
Citation: Ke. Baker et al., SITE OF ANTIARRHYTHMIC ACTION OF NUPAFANT HCL (BB-2113), ASSESSED BY SELECTIVE REGIONAL MYOCARDIAL PERFUSION IN THE RAT-HEART IN-VITRO, British Journal of Pharmacology, 122, 1997, pp. 241-241
ELECTROPHYSIOLOGICAL EFFECTS OF TERFENADINE IN THE GUINEA-PIG LANGENDORFF HEART AND ISOLATED PAPILLARY-MUSCLE PREPARATIONS
Authors: FRASER S TEMPLETON AGB ROTHAUL AL WOOD LM PATMORE L SHERIDAN RD
Citation: S. Fraser et al., ELECTROPHYSIOLOGICAL EFFECTS OF TERFENADINE IN THE GUINEA-PIG LANGENDORFF HEART AND ISOLATED PAPILLARY-MUSCLE PREPARATIONS, British Journal of Pharmacology, 122, 1997, pp. 390-390
SENSITIVITY AND SPECIFICITY OF QEEG IN CHILDREN WITH ATTENTION-DEFICIT OR SPECIFIC DEVELOPMENTAL LEARNING-DISORDERS
Authors: CHABOT RJ MERKIN H WOOD LM DAVENPORT TL SERFONTEIN G
Citation: Rj. Chabot et al., SENSITIVITY AND SPECIFICITY OF QEEG IN CHILDREN WITH ATTENTION-DEFICIT OR SPECIFIC DEVELOPMENTAL LEARNING-DISORDERS, Clinical EEG electroencephalography, 27(1), 1996, pp. 26-34
MATRIX METALLOPROTEINASES AND PROCESSING OF PRO-TNF-ALPHA
Authors: GEARING AJH BECKETT P CHRISTODOULOU M CHURCHILL M CLEMENTS JM CRIMMIN M DAVIDSON AH DRUMMOND AH GALLOWAY WA GILBERT R GORDON JL LEBER TM MANGAN M MILLER K NAYEE P OWEN K PATEL S THOMAS W WELLS G WOOD LM WOOLLEY K
Citation: Ajh. Gearing et al., MATRIX METALLOPROTEINASES AND PROCESSING OF PRO-TNF-ALPHA, Journal of leukocyte biology, 57(5), 1995, pp. 774-777
THROMBIN-ACTIVATABLE PLASMINOGEN (TAPGEN) - A THROMBUS-SELECTIVE THROMBOLYTIC ANTITHROMBOTIC AGENT
Authors: COMER MB CACKETT K WOOD LM KIRWIN P WAUGH A DAWSON KM
Citation: Mb. Comer et al., THROMBIN-ACTIVATABLE PLASMINOGEN (TAPGEN) - A THROMBUS-SELECTIVE THROMBOLYTIC ANTITHROMBOTIC AGENT, Thrombosis and haemostasis, 73(6), 1995, pp. 1305-1305
URINARY-BLADDER DISTENSION - ITS EFFECTS ON CAROTID BARORECEPTOR REFLEX LEFT-VENTRICULAR INOTROPIC RESPONSE IN THE DOG
Authors: WARD J DALY MD WOOD LM
Citation: J. Ward et al., URINARY-BLADDER DISTENSION - ITS EFFECTS ON CAROTID BARORECEPTOR REFLEX LEFT-VENTRICULAR INOTROPIC RESPONSE IN THE DOG, Journal of physiology, 489(3), 1995, pp. 857-868
THE EFFECT OF A NOVEL INHIBITOR OF TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) PROCESSING, BB-1101, IN EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS
Authors: CORKILL DJ WOOLLEY K GUARD S WRIGHT A GALLOWAY WA THOMAS SW ASKEW M BECKETT P DAVIS MH MILLER K STABLER G GEARING A WOOD LM
Citation: Dj. Corkill et al., THE EFFECT OF A NOVEL INHIBITOR OF TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) PROCESSING, BB-1101, IN EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS, British Journal of Pharmacology, 116, 1995, pp. 8-8
BB10010, A DEMULTIMERISED VARIANT OF LD-78, PRODUCES A RAPID INCREASEIN CIRCULATING WHITE BLOOD-CELLS AND CELLS WITH BONE-MARROW REPOPULATING ABILITY
Authors: MCCOURT M BROTHERTON D COMER MB CRIBBES S CZAPLEWSKI L EDWARDS RM HARPER K HUNTER MG WRIGHT E WOOD LM
Citation: M. Mccourt et al., BB10010, A DEMULTIMERISED VARIANT OF LD-78, PRODUCES A RAPID INCREASEIN CIRCULATING WHITE BLOOD-CELLS AND CELLS WITH BONE-MARROW REPOPULATING ABILITY, British Journal of Pharmacology, 116, 1995, pp. 9-9
THROMBOLYTIC ACTIVITY OF THROMBIN-ACTIVATABLE PLASMINOGEN IN THE ANESTHETIZED RABBIT
Authors: CACKETT KS COMER MB GLADWELL S DAWSON KM WOOD LM
Citation: Ks. Cackett et al., THROMBOLYTIC ACTIVITY OF THROMBIN-ACTIVATABLE PLASMINOGEN IN THE ANESTHETIZED RABBIT, British Journal of Pharmacology, 116, 1995, pp. 10-10
EFFECT OF LEXIPAFANT, A SELECTIVE PAF RECEPTOR ANTAGONIST, ON ISCHEMIA-INDUCED CARDIAC-ARRHYTHMIA AND MORTALITY IN THE ANESTHETIZED RABBIT
Authors: CHRISTODOULOU MS ROTHAUL AL WHITTAKER M WOOD LM
Citation: Ms. Christodoulou et al., EFFECT OF LEXIPAFANT, A SELECTIVE PAF RECEPTOR ANTAGONIST, ON ISCHEMIA-INDUCED CARDIAC-ARRHYTHMIA AND MORTALITY IN THE ANESTHETIZED RABBIT, British Journal of Pharmacology, 116, 1995, pp. 40-40
BB-10010 - AN ACTIVE VARIANT OF HUMAN MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA WITH IMPROVED PHARMACEUTICAL PROPERTIES
Authors: HUNTER MG BAWDEN L BROTHERTON D CRAIG S CRIBBES S CZAPLEWSKI LG DEXTER TM DRUMMOND AH GEARING AH HEYWORTH CM LORD BI MCCOURT M VARLEY PG WOOD LM EDWARDS RM LEWIS PJ
Citation: Mg. Hunter et al., BB-10010 - AN ACTIVE VARIANT OF HUMAN MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA WITH IMPROVED PHARMACEUTICAL PROPERTIES, Blood, 86(12), 1995, pp. 4400-4408
MOBILIZATION OF EARLY HEMATOPOIETIC PROGENITOR CELLS WITH BB-10010 - A GENETICALLY-ENGINEERED VARIANT OF HUMAN MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA
Authors: LORD BI WOOLFORD LB WOOD LM CZAPLEWSKI LG MCCOURT M HUNTER MG EDWARDS RM
Citation: Bi. Lord et al., MOBILIZATION OF EARLY HEMATOPOIETIC PROGENITOR CELLS WITH BB-10010 - A GENETICALLY-ENGINEERED VARIANT OF HUMAN MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA, Blood, 85(12), 1995, pp. 3412-3415
STRUCTURE-ACTIVITY-RELATIONSHIPS FOR BB-823 AND RELATED PAF ANTAGONISTS
Authors: WHITTAKER M ASKEW M BEAUCHAMP CL BOWLES SA CACKETT KS CAMPION C CHRISTODOULOU MS CHURCHILL M DAVIDSON AH DAVIS MH DRUMMOND AH GALLOWAY WA GREWAL KS HIGGS AR LONGSTAFF DS MCGUINNESS GP MILLER A PRATT LM SAROGLOU L TIMMIS DJ WILSON RJ WOOD LM
Citation: M. Whittaker et al., STRUCTURE-ACTIVITY-RELATIONSHIPS FOR BB-823 AND RELATED PAF ANTAGONISTS, Journal of lipid mediators and cell signalling, 10(1-2), 1994, pp. 151-152
PROCESSING OF TUMOR-NECROSIS-FACTOR-ALPHA PRECURSOR BY METALLOPROTEINASES
Authors: GEARING AJH BECKETT P CHRISTODOULOU M CHURCHILL M CLEMENTS J DAVIDSON AH DRUMMOND AH GALLOWAY WA GILBERT R GORDON JL LEBER TM MANGAN M MILLER K NAYEE P OWEN K PATEL S THOMAS W WELLS G WOOD LM WOOLLEY K
Citation: Ajh. Gearing et al., PROCESSING OF TUMOR-NECROSIS-FACTOR-ALPHA PRECURSOR BY METALLOPROTEINASES, Nature, 370(6490), 1994, pp. 555-557
AMELIORATION OF EXPERIMENTAL ACUTE-PANCREATITIS WITH A POTENT PLATELET-ACTIVATING-FACTOR ANTAGONIST
Authors: FORMELA LJ WOOD LM WHITTAKER M KINGSNORTH AN
Citation: Lj. Formela et al., AMELIORATION OF EXPERIMENTAL ACUTE-PANCREATITIS WITH A POTENT PLATELET-ACTIVATING-FACTOR ANTAGONIST, British Journal of Surgery, 81(12), 1994, pp. 1783-1785
BB-10010 A DEMULTIMERISED VARIANT OF LD78 PRODUCES A RAPID INCREASE IN MATURE WHITE BLOOD-CELLS
Authors: MCCOURT M COMER MB EDWARDS RM HUNTER MG WOOD LM
Citation: M. Mccourt et al., BB-10010 A DEMULTIMERISED VARIANT OF LD78 PRODUCES A RAPID INCREASE IN MATURE WHITE BLOOD-CELLS, Blood, 84(10), 1994, pp. 10000136-10000136
CYCLIC ETHER ACETAL PLATELET-ACTIVATING-FACTOR (PAF) RECEPTOR ANTAGONISTS .2. IMIDAZO[4,5-C]PYRIDYL DERIVATIVES
Authors: WOOD LM WHITTAKER M TIMMIS DJ THOMPSON TM SAROGLOU L MILLER A DAVIDSON AH CHRISTODOULOU MS CACKETT KS BOWLES SA BEBBINGTON DS
Citation: Lm. Wood et al., CYCLIC ETHER ACETAL PLATELET-ACTIVATING-FACTOR (PAF) RECEPTOR ANTAGONISTS .2. IMIDAZO[4,5-C]PYRIDYL DERIVATIVES, Bioorganic & medicinal chemistry letters, 3(8), 1993, pp. 1499-1504
HUMAN IL-5 BUT NOT IL-3 AND GM-CSF PROMOTES THE SURVIVAL OF GUINEA-PIG PERITONEAL EOSINOPHILS INVITRO
Authors: WEBBER SE DEBRITO FB MCCARTHY C WOOD LM
Citation: Se. Webber et al., HUMAN IL-5 BUT NOT IL-3 AND GM-CSF PROMOTES THE SURVIVAL OF GUINEA-PIG PERITONEAL EOSINOPHILS INVITRO, The American review of respiratory disease, 147(4), 1993, pp. 821-821
Risultati: 1-24 |